CLBT

+ Watchlist + Portfolio

Cellebrite DI Ltd.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $11.24
52-Week Range: $9.58 – $19.98
Market Cap: $2.84B
P/E (TTM): 49.17
EPS (TTM): 0.23
Dividend Yield: —

Advanced Metrics

Price/Book: 5.27
PEG Ratio: —
Return on Equity: 12.42%
Return on Assets: 3.92%
Gross Margin: 82.96%
Operating Margin: 5.30%
Profit Margin: 11.43%
Current Ratio: 1.62
Debt/Equity: 0.04
Total Debt: $23.23M
Free Cash Flow: $124.92M
Revenue Growth: 15.80%
Earnings Growth: -67.90%
Enterprise Value: $2.40B

CLBT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$270.65M	$325.11M	$401.20M	$475.68M
Cost of Revenue	$50.75M	$53.23M	$62.59M	$75.17M
Gross Profit	$219.91M	$271.88M	$338.61M	$400.50M
Research & Development	$80.62M	$84.39M	$98.42M	$113.88M
Selling, General & Admin	$138.24M	$154.26M	$183.29M	$220.15M
Operating Expenses	$218.86M	$238.64M	$281.70M	$334.02M
Operating Income	$1.04M	$33.24M	$56.91M	$66.48M
EBITDA	$130.10M	-$65.41M	-$265.35M	$103.07M
Pretax Income	$120.76M	-$75.56M	-$275.98M	$90.68M
Income Tax	-$45.00K	$5.54M	$7.02M	$12.35M
Net Income	$120.81M	-$81.10M	-$283.01M	$78.33M
Diluted EPS	0.59	-0.43	-1.35	0.31
Diluted Shares	195.39M	190.15M	209.47M	249.90M

CLBT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$87.64M	$189.52M	$191.66M	$124.46M
Receivables	$78.76M	$77.27M	$82.36M	$104.97M
Inventory	$10.18M	$9.94M	$8.94M	$7.60M
Current Assets	$295.93M	$422.08M	$567.59M	$575.85M
Total Assets	$403.29M	$532.88M	$690.57M	$938.85M
Current Liabilities	$207.78M	$253.82M	$295.50M	$369.66M
Total Debt	$15.36M	$14.13M	$10.97M	$22.67M
Total Liabilities	$329.43M	$498.67M	$354.55M	$454.53M
Retained Earnings	$199.24M	$118.14M	-$164.86M	-$86.54M
Shareholders' Equity	$73.86M	$34.21M	$336.02M	$484.32M
Working Capital	$88.15M	$168.26M	$272.09M	$206.19M

CLBT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$20.58M	$102.06M	$132.17M	$173.54M
Capital Expenditure	-$9.09M	-$7.92M	-$10.61M	-$13.22M
Free Cash Flow	$11.49M	$94.14M	$121.56M	$160.32M
Depreciation & Amortisation	$9.19M	$10.01M	$10.61M	$11.87M
Stock-Based Compensation	$13.71M	$19.00M	$30.57M	$44.89M
Investing Cash Flow	-$91.23M	-$22.54M	-$149.47M	-$268.25M
Financing Cash Flow	$13.97M	$21.77M	$20.65M	$25.05M
Dividends Paid	$0.00	$0.00	—	—
Share Repurchases	$0.00	—	—	—
Net Change in Cash	-$56.68M	$101.28M	$3.35M	-$69.65M

CLBT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$107.55M	$113.28M	$126.03M	$128.82M	$128.30M
Cost of Revenue	$17.49M	$17.68M	$20.31M	$19.69M	$22.42M
Gross Profit	$90.06M	$95.60M	$105.72M	$109.13M	$105.88M
Research & Development	$27.28M	$28.61M	$28.12M	$29.86M	$35.87M
Selling, General & Admin	$50.51M	$52.57M	$58.60M	$58.46M	$60.89M
Operating Expenses	$77.79M	$81.18M	$86.72M	$88.33M	$96.76M
Operating Income	$12.27M	$14.42M	$18.99M	$20.80M	$9.12M
EBITDA	$14.90M	$30.52M	$21.69M	$49.47M	$16.12M
Pretax Income	$19.33M	$20.79M	$24.29M	$26.27M	$13.63M
Income Tax	$1.93M	$1.31M	$4.10M	$5.01M	$2.70M
Net Income	$17.40M	$19.48M	$20.19M	$21.26M	$10.94M
Diluted EPS	0.07	0.08	0.08	0.08	0.04
Diluted Shares	249.30M	248.98M	249.72M	251.50M	252.08M

CLBT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$90.47M	$179.22M	$281.36M	$124.46M	$133.69M
Receivables	$81.14M	$93.13M	$104.20M	$104.97M	$72.74M
Inventory	$8.97M	$9.54M	$8.65M	$7.60M	$7.53M
Current Assets	$523.48M	$606.11M	$668.40M	$575.85M	$540.87M
Total Assets	$709.89M	$787.42M	$834.32M	$938.85M	$952.29M
Current Liabilities	$287.80M	$309.97M	$316.92M	$369.66M	$350.21M
Total Debt	$10.60M	$22.33M	$21.44M	$22.67M	$22.80M
Total Liabilities	$346.40M	$379.01M	$386.63M	$454.53M	$441.75M
Retained Earnings	-$147.46M	-$127.99M	-$107.80M	-$86.54M	-$75.60M
Shareholders' Equity	$363.49M	$408.41M	$447.69M	$484.32M	$510.54M
Working Capital	$235.68M	$296.14M	$351.49M	$206.19M	$190.66M

CLBT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$20.88M	$32.58M	$33.27M	$86.81M	$19.89M
Capital Expenditure	-$2.34M	-$3.61M	-$3.32M	-$3.96M	-$10.10M
Free Cash Flow	$18.54M	$28.98M	$29.95M	$82.86M	$9.79M
Depreciation & Amortisation	$2.63M	$2.59M	$2.70M	$3.94M	$7.00M
Stock-Based Compensation	$8.78M	$8.81M	$15.31M	$12.00M	$14.38M
Investing Cash Flow	-$126.50M	$40.58M	$63.79M	-$246.11M	-$13.57M
Financing Cash Flow	$3.62M	$13.83M	$5.27M	$2.34M	$3.51M
Net Change in Cash	-$102.01M	$86.99M	$102.33M	-$156.96M	$9.82M

Market Snapshot

About

Cellebrite DI Ltd. is an Israeli digital intelligence company that provides digital forensics and intelligence solutions to law enforcement, government agencies, and enterprises worldwide. Headquartered in Petah Tikva, Israel, Cellebrite develops technology that enables investigators to extract, decode, and analyze data from mobile devices, computers, and cloud services. The company's platforms are used in criminal investigations, intelligence gathering, and corporate security applications. Cellebrite serves thousands of organizations across more than 100 countries and is a recognized leader in digital evidence collection and analysis.